Correlations between surrogate measures of insulin resistance and cardiovascular risk factors in obese and overweight patients

Journal of Diabetes and its Complications

Volumn 17, Issue 2, 2003, Pages 66-72

  Lerman, Israel ^a   Villa, Antonio R ^a   Ríos Torres, Juan Manuel ^a   Tamez, Laura Elena ^a   Gómez Pérez, Francisco ^a   Del Villar Velasco, Sonia Luna ^a   Rull Rodrigo, Juan Antonio ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Coronary risk factors; Insulin resistance; Obesity

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; CORONARY DISEASE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 0037374608     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00201-5     Document Type: Article

References (35)

1. Consensus development conference on insulin resistance. Diabetes Care. 21:1998;310-314.
2. Belfiore F., Jannello S., Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Molecular Genetics and Metabolism. 63:1988;134-141.
3. Bergman N. The "metabolically obese" normal weight individual. American Journal of Clinical Nutrition. 38:1989;1512-1527.
4. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Targher G., Alberiche M., Bonadonna R.C., Muggeo M. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes. 47:1998;1643-1649.
5. Caro J. Insulin resistance in obese and nonobese man. Journal of Clinical Endocrinology and Metabolism. 73:1991;691-696.
6. Cederholm J., Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Research and Clinical Practice. 10:1990;167-175.
7. DeFronzo R., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and ASCVD. Diabetes Care Reviews. 14:1991;173-194.
8. DeFronzo R.A., Tobin J.D., Andres R. The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin. American Journal of Physiology. 237:1979;E214-E223.
9. Despres J.P., Lamarche B., Mauriege P., Cantin B., Dagenais G.R., Moorjani S., Lupien P.J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. New England Journal of Medicine. 334:1996;952-957.
10. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497.
11. Ferranini E. Insulin resistance and hypersecretion in obesity. Journal of Clinical Investigation. 100:1997;1166-1173.
12. Ferrannini E., Bjorkman O., Reichard G.A., Pilo A., Olsson M., Wahren J., De Fronzo R.A. The disposal of an oral glucose load in healthy sujects. A cuantitative study. Diabetes. 34:1985;580-588.
13. Ferrannini E., Natali A., Bell P., Cavallo-Perin P., Lalic N., Mingrone G. On behalf of the European Group for the Study of Insulin Resistance (EGIR): insulin resistance and hypersecretion in obesity. Journal of Clinical Investigation. 100:1997;1166-1173.
14. Fulcher G.R., Walker M., Alberti K.G.M.M. The assesment of insulin action in vivo. Alberti K.G.M.M., DeFronzo R.A., Keen H., Zimmet P. International textbook of diabetes mellitus. 1992;513-530 Wiley, New York.
15. Ginsberg H. Insulin resistance and cardiovascular disease. Journal of Clinical Investigation. 106:2000;453-458.
16. Haffner S.M., Kennedy E., Gonzalez C., Stern M.P., Miettinen H. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care. 19:1996;1138-1141.
17. Haffner S.M., Miettinen H., Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 20:1997;1087-1092.
18. Hollenbeck C.B., Chen N., Chen Y.-D.I., Reaven G.M. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes. 33:1984;460-463.
19. Kahn B.B., Flier J.S. Obesity and insulin resistance. Journal of Clinical Investigation. 106:2000;473-481.
20. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., Quon M.J. Quantitative insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism. 85:2000;2402-2410.
21. Laakso M. How good a marker is insulin level for insulin resistance? American Journal of Epidemiology. 137:1993;959-965.
22. Lindahl B., Asplund K., Hallmans G. High serum insulin, insulin resistance and their associations with cardiovascular risk factors The Northern Sweden MONICA population study. Journal of Internal Medicine. 234:1993;263-270.
23. Matsuda M., DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care. 22:1999;1462-1470.
24. McAuley K.A., Williams S.M., Mann J.I., Walker R.J., Lewis-Barned N.J., Temple L.A., Duncan A.W. Diagnosing insulin resistance in the general population. Diabetes Care. 24:2001;460-464.
25. Methews D.R., Hosker J.P., Rudensky A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 28:1985;412-419.
26. Modan M., Halkin H., Almong S., Lusky A., Eshkol A., Shelfi M., Shitris A., Fuch Z. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. Journal of Clinical Investigation. 75:1985;809-817.
27. O'Dea K., Rowley K.G. Macrovascular disease risk factors and insulin resistance in Aboriginal and Torres Strait Islander people. Journal of Diabetes and its Complications. 16:2002;9-16.
28. Olefsky J., Farquhar J.W., Reaven G.M. Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes. 22:1973;507-513.
29. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. Journal of Clinical Endocrinology and Metabolism. 85:2000;4426-4433.
30. Reaven G. Banting lecture: role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
31. Reaven G.M. Obesity:basic aspects and clinical implications. Medical Clinics of North America. 73:1989;1-264.
32. Reaven G.M., Brand R.J., Chen Y.D., Mathur A.K., Goldfine I. Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes. 42:1993;1324-1332.
33. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonals J.M., Parrot M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry. 48:2002;436-472.
34. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Järvinen H., Van Haeften T., Renn W., Gerich J. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 23:2000;295-301.
35. Yeni-Komshian H., Carantoni M., Abbasi F., Reaven G.M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care. 23:2000;171-175.